Shandong Xier Kangtai

Shandong Xier Kangtai Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer based in Jining, Shandong Province, China. Founded in 1989, the company specializes in the production of a wide range of generic medications, including oral solid preparations, small-volume injections, and hollow capsules. With a strong focus on international markets, approximately 95% of its sales are derived from exports to regions such as Africa, Southeast Asia, and the Middle East. The company operates high-standard GMP-certified facilities and maintains a portfolio of over 1,000 registered drug products globally. In late 2024, the company was acquired by Yanzhou Huarui Medical Investment Management Co., Ltd., marking a significant shift in its ownership structure.